HLB Life Science Decides to Issue 10 Billion Won Convertible Bonds for Operating Funds... Conversion Price at 3,529 Won (Slightly Above Current Price) but Downward Adjustment Possible
HLB Life Science decided to issue the 17th series unregistered, unsecured private convertible bonds (CB) worth 10 billion KRW for operating funds. Zero coupon rate, 5% yield to maturity, paying 128.2037% of principal at maturity (June 8, 2031).
The conversion price is set at 3,529 won, a 4.4% premium above the current market price (3,380 won as of the base date). However, starting from 7 months after issuance, the conversion price can be adjusted downward to a minimum of 2,471 won (70% of the initial price) if the stock price declines, posing a future dilution risk.
Conversion period is from June 8, 2027 to May 8, 2031, with 2,833,663 new shares issuable upon full conversion (2.32% of outstanding shares). Including existing outstanding CBs, total potential dilution reaches 5.16%.
The investor (Synergy IB K-Bio 1st New Technology Business Investment Association) holds a put option starting 24 months after issuance, with early redemption rates escalating from 110.4486% to 126.6209%.
Collateral is provided: security interests on land and buildings in Pyeongtaek and Hwaseong, with a maximum claim of 130% of principal. This may restrict the company's financial flexibility.
The funds are to be used solely for operating purposes (e.g., raw material purchases), not for growth investments, indicating potential cash flow constraints.
[AI Comprehensive Analysis]While this CB issuance secures short-term operating funds, the downward adjustment clause and collateral provision could dilute existing shareholders' value and increase financial constraints. The use of funds for operational needs rather than growth raises questions about the company's cash generation ability. Investors should be cautious about increased stock price volatility and potential dilution.
KOSDAQ Filing Information
Filing: Report On Major Events (Decision On Issuance Of Convertible Bonds)